Dude, it's been over 4 years now and not only is IsoPet sold at a loss, but revenues are declining, not rising. MK's IsoPet business plan has failed. I don't blame him for that. I blame him for continuing on same path after the business plan has clearly failed. RDGL doesn't have the resources to make IsoPet profitable within remaining runway. The only way to save RDGL now (and IsoPet with it), is to get Radiogel to human trials. There clearly are no remaining options for RDGL to continue operations. Yet, instead of focusing on that, RDGL is wasting time and $ peddling IsoPet at another vet conference.
News 
Market Data 
Discover 
